Colchicine and low dose rivaroxaban after stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial is testing whether a combination of two medicines—colchicine (an anti-inflammatory) and a low dose of rivaroxaban (a blood thinner)—can help prevent future heart attacks, strokes, or other blood vessel problems in people who recently had a stroke caused by a blood clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke caused by a blood clot (ischemic stroke) within the last 14 days
- You are not taking a blood thinner for a condition like atrial fibrillation or a blood clot
- You have never had a bleeding stroke or bleeding inside your skull
- You do not have severe kidney disease (on dialysis or similar)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of blood thinners to prevent another stroke in people who have a narrowed artery in the brain. It compares standard treatment to a combination of low-dose blood thinners to see if this approach works better to prevent future strokes.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This trial tests whether the anti-inflammatory drug colchicine can help prevent a second stroke in people who recently had a mild to moderate ischemic stroke. If you had a stroke 1 to 4 weeks ago and are between 18 and 80 years old, you may be able to join.
This trial tests if a drug called colchicine can reduce the risk of future strokes and improve recovery after a recent brain bleed (intracerebral hemorrhage). It is for people who also have heart or blood vessel disease or multiple risk factors like high blood pressure or diabetes.
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.